Ariana Pharma
Nabsys, Ariana Pharmaceuticals Collaborate to ID Structural Variants Linked to Cancer
The companies will combine Nabsys' technology to identify the structural variants with Ariana's clinical data analysis tools.
WIN Consortium Gets $3.9M to Launch International Personalized Cancer Treatment Trials
NEW YORK (GenomeWeb News) – The WIN Consortium, an International personalized medicine initiative, will use €3 million ($3.9 million) in funding from the European Union to launch an effort to provide tailored cancer treatment regimens to patients based on genetic analysis, the consortium said tod
France Funds $17M Cancer Profiling, Biomarker Effort
NEW YORK (GenomeWeb News) – The French government has provided €13.4 million ($17.4 million) to fund the Innovative MODels Initiative (IMODI), a partnership aimed at facilitating the development of new cancer treatments.
Ariana Pharma, CTCLS Ink Distribution Deal for Japan
NEW YORK (GenomeWeb News) – Ariana Pharma announced today an exclusive distribution deal with CTC Laboratory Systems covering Japan.
Ariana Pharma, a provider of an association rules-based clinical data analysis technology, has tapped Mariana Kuras to serve as its chief technology officer.
Sep 8, 2010
Sep 8, 2010